Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The objectives of this study are to estimate the efficacy and safety of the daily administration for 6 months of 5 mg versus 10 mg. A 6 month follow-up of subjects is carried out to estimate how the effects of mifepristone are kept in time. The hypothesis of this study is that both mifepristone doses reduce the volume of the myoma up to 50% in six months treatment.
Epistemonikos ID: 656a6a9ad1134fc295352580ae36c478d06be98b
First added on: May 05, 2024